✦ LIBER ✦

Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

✍ Scribed by Takenaka, Katsuto; Nagafuji, Koji; Takase, Ken; Kamimura, Tomohiko; Mori, Yasuo; Ito, Yoshikiyo; Nishi, Yukiko; Henzan, Hideho; Kato, Koji; Harada, Naoki; Eto, Tetsuya; Miyamoto, Toshihiro; Teshima, Takanori; Akashi, Koichi

Book ID: 113099311
Publisher: Carden Jennings Publishing
Year: 2012
Tongue: English
Weight: 515 KB
Volume: 96
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-012-1087-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral valganciclovir as preemptive therap

Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

✍ Katsuto Takenaka; Tetsuya Eto; Koji Nagafuji; Kenjiro Kamezaki; Yayoi Matsuo; Go 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 215 KB

Oral valganciclovir is safe and effectiv

Oral valganciclovir is safe and effective as preemptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

✍ E. Ayala; J. Greene; R. Sandin; J. Perkins; T. Field; C. Tate; S.C. Goldstein; H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Valganciclovir is safe and effective as

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

✍ Ayala, E; Greene, J; Sandin, R; Perkins, J; Field, T; Tate, C; Fields, K K; Gold 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Validation of a DNAemia cutoff for preem

Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients

✍ Gerna, G; Lilleri, D; Caldera, D; Furione, M; Zenone Bragotti, L; Alessandrino, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB